Geneva Bioinformatics (GeneBio) SA and the Chinese State Key Laboratory of Proteomics today announced an agreement that sees GeneBio's Phenyx protein identification platform installed on the Chinese State Key Laboratory of Proteomics' High Performance Computing Cluster (32 nodes). The Chinese State Key Laboratory of Proteomics, under the direction of Professor Fuchu He, co-chair of the Human Proteome Organisation's Human Liver Proteome Project (HLPP), is a very prominent actor in the Chinese proteomics effort and also a very active partner of the HUPO HLPP. This license agreement is a further link between GeneBio and numerous HUPO projects, amongst which are the Proteomics Standards Initiative and the HUPO Brain Proteome Project (where Phenyx is installed on the 128 CPU PAULA cluster). This agreement, together with many others that GeneBio has communicated in the previous several months, shows clearly that Phenyx is becoming a key element to any high throughput proteomics project that allows life scientists, thanks notably to its robust algorithm, to produce very reliable results. Developed in collaboration with the Swiss Institute of Bioinformatics (SIB), Phenyx is GeneBio's renowned software platform for the identification and characterization of proteins and peptides from mass spectrometry data, specifically designed to meet the concurrent demands of high-throughput MS data analysis and dynamic results assessment while offering a flexible user experience and an adaptable architecture to help instill confidence in results assessment. (http://phenyx.vital-it.ch/pwi) "We are very pleased to be working with GeneBio and the SIB and believe Phenyx to be the right platform for our cluster," said Professor Yunping Zhu of the Chinese State Key Laboratory of Proteomics. "Our laboratory is keen to provide the best results possible to our community, and for this it was obvious that the addition of Phenyx's capabilities was mandatory. The quality of the identification results together with the suite of features the software provides, amongst which features the possibility to compare results from all major search engines, were very important factors in our decision." "We are very excited about this agreement with the Chinese State Key Laboratory of Proteomics, a renowned laboratory that gives further recognition to Phenyx's excellence and innovations," said Nasri Nahas, CEO of GeneBio. "In light of our work with other HUPO projects, we are happy to be playing a part in furthering the interests of HUPO throughout the world, a witness to GeneBio's continuous endeavour to serve the scientific community as widely as possible. As a commercial organization, we take great pride in this initial major Chinese agreement, which will undoubtedly open the door to many others both in Asia in general and in China particularly."